Friday, September 03, 2021 4:45:59 PM
118) Philippines 131) Thailand
4800 P3 is a global study with a forecast of 7,116 participants distributed among Brazil, Argentina, Colombia, United States of America, Philippines, Mexico, Peru, Poland, Czech Republic and Thailand. Initial studies (Phase 1 and 2) were carried out in the United States, South Korea and China)
4802 P1/2 will be most likely externally funded or partnered, and conducted in S Africa, India, and more countries.
# Country,
Other Total
Cases New
Cases Total
Deaths New
Deaths Total
Recovered New
Recovered Active
Cases Serious,
Critical Tot Cases/
1M pop Deaths/
1M pop Total
Tests Tests/
1M pop Population
1 Peru 2,152,118 198,364 N/A N/A N/A 1,237 64,226 5,920 16,840,906 502,588 33,508,377
2 Hungary 813,040 +247 30,061 +1 777,988 +79 4,991 19 84,414 3,121 6,606,051 685,871 9,631,624
3 Bosnia and Herzegovina 216,124 +811 9,862 +15 192,218 14,044 66,359 3,028 1,148,516 352,640 3,256,910
4 North Macedonia 178,879 +720 6,013 +26 157,868 +574 14,998 85,864 2,886 1,175,766 564,384 2,083,274
5 Gibraltar 5,376 +5 97 5,191 +7 88 1 159,625 2,880 339,904 10,092,461 33,679
6 Czechia 1,680,046 +306 30,405 +1 1,647,382 +7 2,259 10 156,542 2,833 36,219,289 3,374,814 10,732,234
7 Montenegro 117,080 +547 1,748 +15 107,041 +624 8,291 11 186,386 2,783 631,401 1,005,161 628,159
8 Bulgaria 459,051 19,001 407,029 33,021 333 66,653 2,759 4,276,501 620,939 6,887,152
9 Brazil 20,830,712 582,004 19,801,725 446,983 8,318 97,191 2,716 56,897,224 265,470 214,326,515
10 San Marino 5,321 90 5,150 81 1 156,436 2,646 75,461 2,218,528 34,014
11 Argentina 5,195,601 112,195 4,884,418 198,988 2,497 113,737 2,456 22,307,283 488,331 45,680,639
12 Colombia 4,913,031 125,097 4,742,640 45,294 542 95,368 2,428 24,268,743 471,084 51,516,791
13 Slovakia 395,532 +232 12,549 +1 381,335 +84 1,648 27 72,405 2,297 3,336,980 610,862 5,462,738
14 Paraguay 458,716 15,821 437,843 5,052 90 63,403 2,187 1,781,035 246,172 7,234,912
15 Belgium 1,189,710 +2,204 25,392 +10 1,103,638 60,680 192 102,133 2,180 18,779,255 1,612,142 11,648,637
16 Italy 4,559,970 +6,735 129,410 +58 4,293,535 +6,544 137,025 556 75,549 2,144 84,928,897 1,407,092 60,357,722
17 Slovenia 269,248 +610 4,453 258,465 +334 6,330 18 129,491 2,142 1,457,824 701,122 2,079,273
18 Croatia 376,417 +816 8,355 +6 363,906 +597 4,156 57 92,359 2,050 2,573,737 631,498 4,075,606
19 Mexico 3,387,885 +18,138 261,496 +993 2,727,659 +12,616 398,730 4,798 25,958 2,004 9,852,284 75,487 130,516,103
20 Poland 2,889,773 +349 75,372 +5 2,657,274 +97 157,127 58 76,453 1,994 19,819,235 524,345 37,798,076
21 USA 40,607,091 +92,097 663,695 +720 31,226,722 +26,887 8,716,674 25,743 121,843 1,991 589,857,715 1,769,893 333,273,117
https://www.worldometers.info/coronavirus/#countries
Recent INO News
- INOVIO Reports Inducement Grants Under Inducement Plan • PR Newswire (US) • 05/01/2024 12:00:00 PM
- INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024 • PR Newswire (US) • 04/29/2024 12:00:00 PM
- INOVIO to Participate in Upcoming Investor Conferences in May • PR Newswire (US) • 04/29/2024 12:00:00 PM
- INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants • PR Newswire (US) • 04/15/2024 10:39:00 PM
- INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine • PR Newswire (US) • 03/26/2024 10:28:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights • PR Newswire (US) • 03/06/2024 09:05:00 PM
- Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting • PR Newswire (US) • 03/06/2024 12:00:00 PM
- U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb • IH Market News • 03/06/2024 11:02:03 AM
- INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 • PR Newswire (US) • 02/21/2024 01:00:00 PM
- INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • PR Newswire (US) • 02/07/2024 04:46:00 PM
- INOVIO Reports Inducement Grant Under Inducement Plan • PR Newswire (US) • 02/02/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:24 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:01:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:02:31 PM
- INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split • PR Newswire (US) • 01/23/2024 01:00:00 PM
- INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader • PR Newswire (US) • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:27:59 PM
- INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi) • PR Newswire (US) • 01/04/2024 01:00:00 PM
- INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program • PR Newswire (US) • 01/03/2024 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:05:57 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:00:28 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 09:35:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:59 PM
- INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights • PR Newswire (US) • 11/09/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:00:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM